Infezioni delle vie respiratorie

Uso degli antibiotici in età pediatrica: riflessioni e azioni

Marchetti F.

2024/7 — pag. 450-457 — DOI

The annual report on the national use of antibiotics in Italy for the year 2022 was published by AIFA (Italian Medicines Agency). The report confirms an increase in antibiotic use post-pandemic, particularly in the paediatric population. There is a n...

Quel che resta della prevenzione delle otiti (e infezioni respiratorie): xilitolo e dintorni

Marchetti F.

2024/3 — pag. 176-178 — DOI

Over the years, the prevention of episodes of upper respiratory tract infections and in particular of acute otitis media has always been discussed. A recent randomized controlled clinical trial has re-proposed the evaluation of the efficacy of a natu...

Le infezioni respiratorie ricorrenti

D. Ferrara, M.C. Vella

2020/2 — pag. 85-91

Recurrent respiratory tract infections (RRI) constitute an important public health problem, they are among the main causes of morbidity in paediatric age and one of the most frequent reasons for prescribing antibiotics. Their management has a signi...

Psoriasi guttata Granuloma anulare

2017/3 — pag. 198

L'uso del miele nella tosse acuta

D. Sambugaro, F. Fusco

2012/5

Infezioni delle vie respiratorie e antibiotico: sì, no, quando?

F. Marchetti, F. Panizon

2010/9 — pag. 577-584

It is reasonable to delay the antibiotic treatment of a few days in all the apparently not serious cases of upper respiratory infection. “Risk” groups, in which antibiotics should be used to treat each fever, are: chronic pulmonary, kidney and hear...

Un breve ciclo di montelukast, iniziato ai primi segni di asma intermittente, determina una modesta riduzione della gravità degli episodi

D. Radzik

2008/1